Routine versus selective antifungal administration for control of fungal infections in patients with cancer

Medicin og biovidenskab

• Mycoses 100%
• Amphotericin B 78%
• Fluconazole 65%
• Miconazole 59%
• Neutropenia 56%
• Ketoconazole 52%
• Itraconazole 50%
• Confidence Intervals 50%
• Voriconazole 35%
• Mortality 35%
• Neoplasms 31%
• Invasive Fungal Infections 18%
• Antifungal Agents 16%
• Pharmaceutical Preparations 11%
• PubMed 11%
• Fever 10%
• Data Analysis 10%
• Placebos 9%
• Randomized Controlled Trials 9%
• Morbidity 8%
• Therapeutics 6%
• Incidence 6%